DK1490024T3 - Alendronatholdige brusesammensætninger - Google Patents

Alendronatholdige brusesammensætninger

Info

Publication number
DK1490024T3
DK1490024T3 DK03716287.2T DK03716287T DK1490024T3 DK 1490024 T3 DK1490024 T3 DK 1490024T3 DK 03716287 T DK03716287 T DK 03716287T DK 1490024 T3 DK1490024 T3 DK 1490024T3
Authority
DK
Denmark
Prior art keywords
alendronate
shower compositions
containing shower
compositions
effervescent
Prior art date
Application number
DK03716287.2T
Other languages
English (en)
Inventor
David Mccallister
Christer Rosen
Original Assignee
Effrx Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Effrx Pharmaceuticals Sa filed Critical Effrx Pharmaceuticals Sa
Application granted granted Critical
Publication of DK1490024T3 publication Critical patent/DK1490024T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
DK03716287.2T 2002-03-06 2003-03-06 Alendronatholdige brusesammensætninger DK1490024T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9208302A 2002-03-06 2002-03-06
PCT/US2003/006576 WO2003075884A1 (en) 2002-03-06 2003-03-06 Effervescent compositions comprising bisphosphonates and methods related thereto

Publications (1)

Publication Number Publication Date
DK1490024T3 true DK1490024T3 (da) 2012-04-10

Family

ID=27804153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03716287.2T DK1490024T3 (da) 2002-03-06 2003-03-06 Alendronatholdige brusesammensætninger

Country Status (8)

Country Link
US (1) US20060240103A1 (da)
EP (2) EP1490024B1 (da)
AT (1) ATE541575T1 (da)
AU (1) AU2003219999A1 (da)
CA (1) CA2495886C (da)
DK (1) DK1490024T3 (da)
ES (2) ES2448501T3 (da)
WO (1) WO2003075884A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
RU2361867C2 (ru) * 2004-11-23 2009-07-20 Донг Вха Фармасьютикал. Инд. Ко., Лтд. Диметансульфонат n-гидрокси-4{5-[4-(5-изопропил-2-метил-1, 3-тиазол-4-ил)фенокси]пентокси}бензамидина
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
FR2952815B1 (fr) 2009-11-25 2012-01-06 Oreal Produit cosmetique
US20110281008A1 (en) * 2010-04-13 2011-11-17 Amerilab Technologies, Inc. Effervescent tablet with improved dissolution time and method of using the same
CA2820019A1 (en) * 2010-12-06 2012-06-14 Effrx Pharmaceuticals Sa Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
WO2016042372A1 (en) 2014-09-17 2016-03-24 Steer Engineering Private Limited Effervescent composition and method of making it
BR112017009743A2 (pt) * 2014-11-17 2018-02-20 Kraft Foods Group Brands Llc produto de bebida com tartarato de sódio e potássio
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN106924257B (zh) * 2017-03-14 2019-11-19 湖南赛隆药业有限公司 质子泵抑制剂和抗骨质疏松药的复合物及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5858146A (ja) 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
IT1195993B (it) * 1984-01-12 1988-11-03 Gentili Ist Spa Forme farmaceutiche a base di difosfonati
US4687662A (en) 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
US4710384A (en) 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US4942039A (en) 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
US5348745A (en) 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
ES2074769T3 (es) * 1991-07-01 1995-09-16 Gergely Gerhard Procedimiento para la elaboracion de un preparado farmaceutico con, al menos, dos principios activos diferentes y uso de un preparado de este tipo.
DE59201238D1 (de) 1991-07-01 1995-03-02 Gerhard Gergely Reaktionsdotierte brausesysteme.
FR2698788B1 (fr) 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
US5639475A (en) 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5853759A (en) 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
ATE256456T1 (de) * 1996-05-17 2004-01-15 Merck & Co Inc Biphosphonat-formulierung mit brausewirkung
US5994329A (en) * 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6015801A (en) 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
IT1293764B1 (it) 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
ATE385797T1 (de) * 1999-12-03 2008-03-15 Univ California At San Diego Phosphonatverbindungen
JP2001253827A (ja) 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法

Also Published As

Publication number Publication date
CA2495886A1 (en) 2004-09-18
CA2495886C (en) 2011-05-03
EP1490024B1 (en) 2012-01-18
EP2277503B1 (en) 2014-02-12
WO2003075884A1 (en) 2003-09-18
AU2003219999A1 (en) 2003-09-22
ATE541575T1 (de) 2012-02-15
EP2277503A1 (en) 2011-01-26
ES2448501T3 (es) 2014-03-14
EP1490024A1 (en) 2004-12-29
US20060240103A1 (en) 2006-10-26
ES2380924T3 (es) 2012-05-21

Similar Documents

Publication Publication Date Title
WO2004035004A3 (en) Effervescent compositions comprising bisphosphonates and methods related thereto
TW200420573A (en) Bifunctional heterocyclic compounds and methods of making and using same
DE60232456D1 (de) Härtbare zusammensetzung
DE60223654D1 (de) Resistzusammensetzung
DE60225282D1 (de) Lotzusammensetzung
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
DE60222293D1 (de) Härtbare harzzusammensetzung
AU2002367773A8 (en) Fab i inhibitors
NO20035775L (no) 3-fluor-pyrrolidiner som anti-diabetesmidler
EP1446114A4 (en) COMPOSITIONS AND METHODS FOR TREATING OSTEOPOROSIS
DE50212117D1 (de) Optoelektronisches bauelement
DE50210938D1 (de) Optoelektronisches bauelement
DK1490024T3 (da) Alendronatholdige brusesammensætninger
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
DE60214367D1 (de) Härtbare zusammensetzung
DK1265911T3 (da) 17-alfa-substitueret-11-beta-substitueret-4-aryl og 21-substitueret 19-norpregnadiendion som antiprogestationelle midler
GB2380486B (en) Photopolymerizable dental coating composition
DK1461047T3 (da) Sammensætninger og fremgangsmåde til behandling af dyr
SG153647A1 (en) Antineoplastic combinations
DE60225790D1 (de) Halbleiterbauelement
GB0312143D0 (en) Lava II
HK1074453A1 (en) Hardenable cyanate compositions
NO20035159D0 (no) Herdbar umettet resin sammensetning
DE60205606D1 (de) Organoborverbindungsabfallstrombehandlung durch wasserstoffperoxid
WO2002070457A8 (en) Inhibitor of monoamine uptake